Cambridge Healthtech Institute’s 20th Annual

Proteomics-Driven Drug Discovery

Effective Use of Chemoproteomics, Chemical Biology, and Phenotypic Screening

September 26-27, 2023

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s conference on Proteomics-Driven Drug Discovery focuses on the use of mass spectrometry, biochemical, biophysical, cell-based assays, and AI/ML for target identification/deconvolution, lead discovery/optimization, and more. The conference brings together experts from academia and pharma/biotech to share ideas and case studies on how new chemical probes, proteomic assays, and screening platforms can be effectively used in drug discovery.

Who should attend: Scientist in Molecular and Cellular Biology, Discovery Biology, Target Discovery, Medicinal Chemistry, Discovery Chemistry, Lead Discovery, Target Identification and Validation, Chemical Biology, Proteomics, Computational Screening, Assay Development and Screening.

Coverage will include, but is not limited to:

Chemoproteomic and mass spectrometry-based strategies
Label-free profiling, activity-based protein profiling, photoaffinity labeling, fluorescence assays
Reactive electrophile compound library screening; design of new chemical probes
Proximity-based methods for protein stabilization, degradation, and more
Emerging biophysical and cellular assays for studying target engagement and interactions
Phenotypic versus target-based screening approaches
Use of computational tools for protein structure predictions, pathway deconvolution, and more
Interactomics approaches toward discovery of disease-driven neoPPIs
Chemical genetics strategies for drug discovery

The deadline for priority consideration is March 17, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: